MedPharm, a Guildford, UK-based topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announced a merger with Tergus Pharma, a Research Triangle Park, NC-based end-to-end contract service provider and a Great Point Partners portfolio company. The combined organization will operate under the MedPharm name, establishing an end-to-end CDMO with scientific, [...]The post MedPharm and Tergus Pharma Merge appeared first on FinSMEs.
Tergus is a North Carolina-based CDMO that provides services such as formulation development, cGMP testing and process validation for the pharmaceutical sector.